Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

The incidence rate of cases increased 6.7% per year on average between 2011 and 2021, the JAMA-published research revealed.

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...

The Mike Slive Foundation has named the recipients of six prostate cancer research grants. The grants are aimed at continuing the foundation’s stated mission ...

"We are trying to develop epigenetic biomarkers that can predict patients that are starting to progress to neuroendocrine prostate cancer," says Jindan Yu, MD, PhD. In this video, Jindan Yu, MD, PhD, ...

Life Expectancy Though life expectancy is a huge part of deciding whether to treat prostate cancer, not enough doctors talk about it with their patients, according to Michael Leapman, MD ...

LONDON — The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTO TM a new treatment for advanced-stage prostate ...

Exxon Mobil also donated $10 million to MD Anderson Cancer Center a decade ago to launch the cancer prevention program in its inaugural community. The University of Texas MD Anderson Cancer Center ...